Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

PROOF OF NON-DISCLOSURE: From the 10K:

Prurisol



The Company has commenced a randomized, double-blind, parallel-group, placebo-controlled Phase 2b trial of Prurisol for subjects with moderate to severe plaque psoriasis. The treatment group arms are Prurisol 300mg, Placebo, Prurisol 400mg (Ratio 3:3:1) with a treatment duration of 12 weeks.



We have currently completed enrollment of all subjects (up to 199). Subject recruitment was slower than projected due to competitive trials. In response, we added additional investigator sites. We expect to complete the trial by calendar year end 2017. Expenditures on Prurisol were approximately $4.6 million during the year ended June 30, 2017. We expect expenditures on Prurisol to increase in future reporting periods, as we complete the study. We have entered into multiple non-disclosure agreements with large pharmaceutical companies that enable us to continue ongoing discussions regarding potential partnering should the trial results support such a relationship.

______________________________

That is fresh off the press today. Also, listen to the audio - Dr. B states that they have agreements with Kevetrin and Brilacidin as well. This is going to blow up soon - just need to confirm how much with the data.